FDA Adverse Event Injury Summary report: N

ANEURX AAADVANTAGE STENT GRAFT SYSTEM-HYDRO

MDR report key: 1760623 · Received July 14, 2010

Report

Report Number
2953200-2010-01307
Event Type
Injury
Date Received
July 14, 2010
Date of Event
June 14, 2010
Report Date
June 14, 2010
Manufacturer
MEDTRONIC CARDIOVASCULAR GALWAY
Product Code
MIH
PMA / PMN Number
P990020
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4): EVALUATION RESULTS: (ENDOLEAK), (REVERSE-FUNNEL SHAPED AORTIC NECK).

Description of Event or Problem · 1

AN ANEURX STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR ENDOVASCULAR TREATMENT OF A 5 CM ABDOMINAL AORTIC ANEURYSM APPROXIMATELY 48 MONTHS AGO. VESSEL MORPHOLOGY AT THE TIME OF IMPLANT WAS NOT REPORTED. IT WAS REPORTED THAT THE PATIENT PRESENTED SYMPTOMATICALLY APPROXIMATELY 1 MONTH AGO, AND THE CT DEMONSTRATED THAT THE BIFURCATED STENT GRAFT (MFR REPORT # 2953200-2010-01306) HAD MIGRATED 10 MM DISTALLY, RESULTING IN A PROXIMAL TYPE I ENDOLEAK. AT THE TIME OF MIGRATION, THE ANEURYSM WAS 8 CM IN DIAMETER, AND THE VESSEL MORPHOLOGY WAS REPORTED AS MILD TORTUOSITY AND MILD CALCIFICATION. THE AORTIC NECK WAS 23 MM IN LENGTH, REVERSE-FUNNEL SHAPED AND RANGED IN DIAMETER FROM 22 MM TO 30 MM DISTALLY, AND HAD ANGULATION OF 20 DEGREES. THE CAUSE OF THE MIGRATION WAS ATTRIBUTED TO DISEASE PROGRESSION WITH AORTIC NECK DILATION. THE PHYSICIAN ELECTED TO INTERVENE FOR THE ENDOLEAK AND MIGRATION WITH ANEURX AORTIC CUFF HOWEVER, THE AORTIC CUFF WAS PLACED LOWER THAN INTENDED, AND THERE WAS STILL A TYPE I ENDOLEAK. THE PHYSICIAN THEN PLACED A 30 MM TALENT AORTIC CUFF, WHICH SUCCESSFULLY RESOLVED THE TYPE I ENDOLEAK. NO ADDITIONAL CLINICAL SEQUELAE REPORTED, AND THE PATIENT IS FINE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ANEURX AAADVANTAGE STENT GRAFT SYSTEM-HYDRO MIH MEDTRONIC CARDIOVASCULAR GALWAY NA V00307813

Patients

Seq Age Sex Outcome Treatment
1 61 YR Required Intervention